CSIMarket


Kewaunee Scientific Corporation  (KEQU)
Other Ticker:  
 


 

Kewaunee Scientific Corporation

KEQU's Financial Statements and Analysis



Kewaunee Scientific Corporation reported in the third quarter of 2024 net earnings per share of $0.85 an increase by 240 % year on year from $0.25 and decline of -8.6 % from $0.93 earned in II. Quarter (Oct 31 2023).


third quarter of 2024
Earnings Per Share Revenues
$ 0.85 $  46 Mill
$+0.60     +240 % $-15M     -24.32 %



Kewaunee Scientific's Revenue fell by -24.32 % in third quarter of 2024 (Jan 31 2024) year on year, to $46 million and declined by -6.95 % sequentially.


Kewaunee Scientific is

More on KEQU's Income Statement



Kewaunee Scientific's net income of $2.533 million in the third quarter of 2024 increased by 130.69 % from net earnings of $1.098 million achieved in III. Quarter a year ago.

Sequentially net earnings fell by -10.49 % from net income of $2.830 million realized in previous quarter.

More on KEQU's Growth

Kewaunee Scientific Inventories
Inventories grew by 2.02 % to $22 million from III. Quarter a year ago, sequentially inventories rose by 0.83 %. KEQU's Cash flow In the third quarter of 2024 company's net cash flow was $5 million, capital expenditures grew by -0.643-26.13%, to $0 millions compare to same quarter a year ago

More on KEQU's Cash flow Statement


Kewaunee Scientific Corporation does not pay out common stock dividend.

In trailing twelve-month period Kewaunee Scientific Corporation earned $ 6.13 cash per share, on a free-cash flow basis 207.1 % of net earning per share.

Book value grew by 3.24 % sequentially to $15.29 per share, 95.04% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 15.29 per share from $ 14.81.

Company issued 0.03 million shares or 1.16 % in Jan 31 2024.
Interest Coverage Ratio was 9.02. Debt Coverage Ratio was 17.68.

More on KEQU's Dividends

 Market Capitalization (Millions) 104
 Shares Outstanding (Millions) 3
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 198
 Net Income (TTM) (Millions $) 9
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) -6
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1,357




Kewaunee Scientific Corporation does not pay out common stock dividend.

In trailing twelve-month period Kewaunee Scientific Corporation had $ 6.13 cash flow per share, on a free-cash flow basis 207.1 % of net earning per share.

Book value grew by 3.24 % sequentially to $15.29 per share, 95.04% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 15.29 per share from $ 14.81.

Company issued 0.03 million shares or 1.16 % in Jan 31 2024.
Interest Coverage Ratio was 9.02. Debt Coverage Ratio was 17.68.

More on KEQU's Balance Sheets

 Market Capitalization (Millions) 104
 Shares Outstanding (Millions) 3
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 198
 Net Income (TTM) (Millions $) 9
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) -6
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1,357
   


  News about Kewaunee Scientific Corporation Earnings

Company Weathered Revenue Contraction with Resilience in Recent Financial Report

The stock market is a dynamic and ever-changing landscape, with companies constantly striving to improve their financial standing and deliver value to their shareholders. In this regard, KEQU, also known as Kewaunee Scientific Corporation, has recently announced some truly astonishing income improvements.
According to their third-quarter financial report for 2024, KEQU reported an impressive income improvement of 240%, reaching an impressive $0.85 per share. This remarkable achievement is even more notable considering the backdrop of a fading revenue, which decreased by -24.321% to $46.03 million. Despite this decline, KEQU has managed to significantly boost its profitability, showcasing the company's st...

The company declared challenging business environment, in the August to October 31 2023 time-frame

Kewaunee Scientific Corporation, a l...

Kewaunee Scientific Corporation Reports Declining Revenue in First Quarter of 2024, But Remains Profitable



Kewaunee Scientific Corporation, a prominent Laboratory Analytical Instruments company, recently released its financial results for the fiscal first quarter of 2024. Despite a decline in revenue, the company managed to achieve profitability, indicating certain positive developments for shareholders. This article will analyze the financial results and examine how they may impact the company's future.
1. Revenue Decline:
Kewaunee Scientific Corporation experienced a decrease in revenue by -2.412% to $48.91 million compared to the previous year. This decline can pose challenges, as it signifies a potential slowdown in sales growth. However, it is essential to consider the reasons behind the dr...

Kewaunee Scientific Corp. Shocks with Spectacular Turnaround: Q4 Report Reveals Stellar 8.5% YoY Revenue Boost, Regains Profitability

Kewaunee Scientific Corp Shows Impressive Revenue Growth and Profitability, Stock Set to Rise
Kewaunee Scientific Corp, a leading Laboratory Analytical Instruments company, has reported a remarkable year-on-year revenue growth of 8.591% in the fiscal span closing April 30, 2023. The company's revenue reached a whopping $53.99 million, which has played a significant role in helping them attain profitability once again. This achievement is reflected in their earnings per share of $0.32, demonstrating a positive trajectory for the company.
In contrast to the third quarter, where revenue slightly deteriorated by -11.238% from $60.82 million, Kewaunee Scientific Corp managed to witness an incredible incom...


Date modified: 2024-03-10T17:33:28+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com